Basel, Switzerland
Basel, Switzerland

Lonza Group is a Swiss chemicals and biotechnology company, headquartered in Basel. The firm provides a number of products and services to the pharmaceutical and life science industries, including organic fine and performance chemicals, custom manufacturing of biopharmaceuticals, chemical synthesis capabilities and chemicals, detection systems and services for the bioscience sector. Wikipedia.


Time filter

Source Type

North America is estimated to hold a whopping 45.3% value share in the global GMP cell banking services market by the end of 2017 and will witness an increase of 231 basis points in market share by 2025 over 2017. The North America regional market will create absolute $ opportunity of US$ 23 Mn in 2018 over 2017. In a new report titled "Global Market Study on GMP Cell Banking Services: Mammalian Cell Type Segment Revenue Projected to Grow 3.2x by 2025 End as Compared to that in 2017," Persistence Market Research forecasts revenue from the North America market to grow 3.1x by 2025 end as compared to that in 2017. This will directly impact the global GMP cell banking services market, which will likely grow from US$ 346.6 Mn in 2017 to US$ 1,012.4 Mn by the end of 2025, translating into a CAGR of 14.3% during the eight year forecast period 2017 - 2025. Strategic industry consolidations and increase in demand for Ready-to-Use (RTU) Bioassay Banks is trending the global GMP cell banking services market One of the key objectives of the report is to identify the key trends governing the global GMP cell banking services market and present a clear picture of the various forces impacting the market at a micro and macro level. A sustained growth of the market can be attributed to macro-economic drivers such as increased public and private sector funding for disease research, which is expected to bring newer therapies to the market; high costs of clinical development; and various collaborative initiatives to identify therapies for difficult-to-treat illnesses. On the supply side, an expansion of production facilities by key players to meet growing customer demand besides offering customized solutions based on specific customer needs (this involves strategic tie-ups between biopharmaceutical companies and cell banking service providers) are some of the factors likely to push the global GMP cell banking services market ahead in the coming years. The report also identifies certain demand side drivers boosting the market such as a growing number of biologics in development currently, limited in-house storage and testing capabilities and a rise in the demand for outsourcing and contract manufacturing. While the above growth factors are indicative of a mature market, Persistence Market Research identifies certain pull factors likely to restrain the market to a certain extent in the coming years. First off, the global GMP cell banking services market is highly fragmented with multiple vendors offering a variety of services - resulting in limited global reach. Besides, complexities in the production and manufacturing processes, a constantly evolving technology landscape, and inconsistent demand for services are likely to restrain revenue growth of the global GMP cell banking services market during the forecast period. Persistence Market Research predicts a large opportunity for key players in the fast growing Asia Pacific region. It must be noted that there has been a shift of R&D and technology investments in the healthcare industry from North America and Europe to Asia Pacific with developing APAC economies such as India offering increased scope for outsourcing of biotech projects owing to ample skilled and qualified manpower at optimal costs. A sample of this report is available upon request@ http://www.persistencemarketresearch.com/samples/13735 Mammalian cell type segment to retain its pole position throughout the forecast period Among the cell type segments, the Mammalian segment was the dominant segment in 2016 and is expected to retain its dominance through 2025. From an estimated US$ 216 Mn in 2017 to a market valuation in excess of US$ 680 Mn by the end of the forecast period, the Mammalian segment will register the highest CAGR of 15.6% among the other cell type segments. The Microbial segment is the second most attractive cell type segment in the global GMP cell banking services market in terms of revenue. Registering a value CAGR of 12.9% between 2017 and 2025, the Microbial segment will hold the second position among the cell type segments of the global GMP cell banking services market. Biopharmaceutical Companies will be the largest end users of GMP cell banking services Among the end user segment of the global GMP cell banking services market, the Biopharmaceutical Companies segment will emerge the undisputed leader both in terms of market share (estimated to hold almost 69% share by 2017 end) and CAGR (an impressive 15.4% during 2017 - 2025). In comparison, the Contract Manufacturing Organizations segment will come a pale second, recording a market attractiveness index of 0.5 during the forecast period. Request to View Report Table of Contents, Figures, and Tables @ http://www.persistencemarketresearch.com/market-research/gmp-cell-banking-service-market/toc The top companies profiled in the report include Wuxi AppTec, Charles River Laboratories International Inc, Eurofins Scientific, Merck KGaA, Lonza Group Ltd., SGS Ltd., ViruSure GmbH, Austrianova, Goodwin Biotechnology Inc., and Paragon Bioservices Inc. Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance. To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.


North America is estimated to hold a whopping 45.3% value share in the global GMP cell banking services market by the end of 2017 and will witness an increase of 231 basis points in market share by 2025 over 2017. The North America regional market will create absolute $ opportunity of US$ 23 Mn in 2018 over 2017. In a new report titled "Global Market Study on GMP Cell Banking Services: Mammalian Cell Type Segment Revenue Projected to Grow 3.2x by 2025 End as Compared to that in 2017," Persistence Market Research forecasts revenue from the North America market to grow 3.1x by 2025 end as compared to that in 2017. This will directly impact the global GMP cell banking services market, which will likely grow from US$ 346.6 Mn in 2017 to US$ 1,012.4 Mn by the end of 2025, translating into a CAGR of 14.3% during the eight year forecast period 2017 - 2025. Strategic industry consolidations and increase in demand for Ready-to-Use (RTU) Bioassay Banks is trending the global GMP cell banking services market One of the key objectives of the report is to identify the key trends governing the global GMP cell banking services market and present a clear picture of the various forces impacting the market at a micro and macro level. A sustained growth of the market can be attributed to macro-economic drivers such as increased public and private sector funding for disease research, which is expected to bring newer therapies to the market; high costs of clinical development; and various collaborative initiatives to identify therapies for difficult-to-treat illnesses. On the supply side, an expansion of production facilities by key players to meet growing customer demand besides offering customized solutions based on specific customer needs (this involves strategic tie-ups between biopharmaceutical companies and cell banking service providers) are some of the factors likely to push the global GMP cell banking services market ahead in the coming years. The report also identifies certain demand side drivers boosting the market such as a growing number of biologics in development currently, limited in-house storage and testing capabilities and a rise in the demand for outsourcing and contract manufacturing. While the above growth factors are indicative of a mature market, Persistence Market Research identifies certain pull factors likely to restrain the market to a certain extent in the coming years. First off, the global GMP cell banking services market is highly fragmented with multiple vendors offering a variety of services - resulting in limited global reach. Besides, complexities in the production and manufacturing processes, a constantly evolving technology landscape, and inconsistent demand for services are likely to restrain revenue growth of the global GMP cell banking services market during the forecast period. Persistence Market Research predicts a large opportunity for key players in the fast growing Asia Pacific region. It must be noted that there has been a shift of R&D and technology investments in the healthcare industry from North America and Europe to Asia Pacific with developing APAC economies such as India offering increased scope for outsourcing of biotech projects owing to ample skilled and qualified manpower at optimal costs. A sample of this report is available upon request@ http://www.persistencemarketresearch.com/samples/13735 Mammalian cell type segment to retain its pole position throughout the forecast period Among the cell type segments, the Mammalian segment was the dominant segment in 2016 and is expected to retain its dominance through 2025. From an estimated US$ 216 Mn in 2017 to a market valuation in excess of US$ 680 Mn by the end of the forecast period, the Mammalian segment will register the highest CAGR of 15.6% among the other cell type segments. The Microbial segment is the second most attractive cell type segment in the global GMP cell banking services market in terms of revenue. Registering a value CAGR of 12.9% between 2017 and 2025, the Microbial segment will hold the second position among the cell type segments of the global GMP cell banking services market. Biopharmaceutical Companies will be the largest end users of GMP cell banking services Among the end user segment of the global GMP cell banking services market, the Biopharmaceutical Companies segment will emerge the undisputed leader both in terms of market share (estimated to hold almost 69% share by 2017 end) and CAGR (an impressive 15.4% during 2017 - 2025). In comparison, the Contract Manufacturing Organizations segment will come a pale second, recording a market attractiveness index of 0.5 during the forecast period. Request to View Report Table of Contents, Figures, and Tables @ http://www.persistencemarketresearch.com/market-research/gmp-cell-banking-service-market/toc The top companies profiled in the report include Wuxi AppTec, Charles River Laboratories International Inc, Eurofins Scientific, Merck KGaA, Lonza Group Ltd., SGS Ltd., ViruSure GmbH, Austrianova, Goodwin Biotechnology Inc., and Paragon Bioservices Inc. Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance. To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.


Global Mycoplasma Diagnostics Market: Scope of the Report The market overview section of the report explores the market dynamics such as drivers, restraints, and opportunities that currently have a strong impact on the global mycoplasma diagnostic market and could influence the market in the near future. Market attractiveness analysis has been provided in all the sections of the report in order to explain the intensity of competition in the market across different products/techniques /end-users/geographies. The competitive scenario among different market players is evaluated through market share analysis in the competition landscape section of the report. The section also includes completion matrix that analyzes the competition among some of the top global players operating in the market. All these factors would help market players to take strategic decisions in order to strengthen their positions and expand their shares in the global market. Global Mycoplasma Diagnostics Market: Key Segments The global mycoplasma diagnostics market has been studied based on major product segments, technique segment, their end-users, and regional as well as national markets. Based on product type, the global market has been categorized into three major 4 segments: Kits & reagents, instruments, software's & services. On the basis of technology the mycoplasma diagnostics market are classified as PCR (Polymerase Chain Reaction), Immunoassay (ELISA, RIA), DNA staining, Microbial Culture Techniques, Others. On the basis of end users the market has been classified as hospitals, diagnostic laboratories, clinics and others. The market for these segments has been extensively analyzed based on their utility, effectiveness, sales, and geographic presence. Market revenue in terms of US$ Mn and market volume in terms of units for the period from 2014 to 2024 along with the compound annual growth rate (CAGR %) from 2016 to 2024 are provided for all segments, considering 2015 as the base year. Global Mycoplasma Diagnostics Market: Regional Outlook Geographically, the mycoplasma diagnostic market has been segmented into five regions: North America, Europe, Asia Pacific, Europe, Middle East & Africa (MEA), and Latin America. Each regional market for microfluidics has been further categorized into major product, technology, and end-user segments considered within the scope of the study. Key country (U.S., Canada, Japan, Germany, France, U.K., Canada, China, Brazil, Mexico, India, etc.) market revenues have also been provided in different regional sections within the report. Market revenue in terms of US$ Mn for the period from 2014 to 2024 along with CAGR % from 2016 to 2024 are provided for all the regions and nations considering 2015 as the base year. Companies Mentioned in the Report The report also profiles key players operating in the microfluidics market based on various attributes such as company details, SWOT analysis, strategic overview, financials, and business overview. Major players profiled in this report include F. Hoffmann-La Roche Ltd., Agilent Technologies, Sartorius Stedim BioOutsource Limited, Savyon Diagnostics, Takara Bio Inc. (Takara Holding Company Inc.), Lonza Group, Merck KGaA, and Charles River Laboratories International, Inc. among others. The global mycoplasma diagnostics market is segmented as follows: Mycoplasma Diagnostics Market, by Product Kits & Reagents Instruments Software & Services Mycoplasma Diagnostics Market, by Technology PCR Immunoassay ELISA RIA DNA staining Microbial Culture Techniques Others Mycoplasma Diagnostics Market, by End Users Hospitals Diagnostic Laboratories Clinics Others Global Multiplexed Diagnostics Market, by Region North America U.S. Canada Europe Germany U.K. France Italy Spain Rest of Europe Asia Pacific India China Japan Rest of Asia Pacific Latin America Brazil Mexico Rest of Latin America Middle East & Africa Saudi Arabia South Africa Download the full report: https://www.reportbuyer.com/product/4885785/ About Reportbuyer Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers http://www.reportbuyer.com For more information: Sarah Smith Research Advisor at Reportbuyer.com Email: query@reportbuyer.com Tel: +44 208 816 85 48 Website: www.reportbuyer.com To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/mycoplasma-diagnostics-market-dna-staining-and-microbial-culture-techniques-end-users---hospitals-diagnostic-laboratories-and-clinics---global-industry-analysis-size-share-growth-trends-and-forecast-2016---2024-300453774.html


News Article | May 10, 2017
Site: marketersmedia.com

— Rising R&D investments in life sciences, increasing healthcare expenditure levels, increased number of patients suffering from infectious diseases, rapidly increasing new drug launches, increasing applications of PCR technologies in the field of life science, growing biotechnology & pharmaceutical companies, technological advancements and increasing government support are some of the factors favouring the mycoplasma testing market. However, stringent government regulations and high degree of consolidation for new entrants are hampering the market. Polymerase Chain Reaction (PCR) technology is projected to witness substantial breakthrough advancements over the coming decade and is expected to provide lucrative avenues of growth. In 2016, kits & reagents products accounted for the largest market share due to repeated purchase of these products. Pharmaceutical and biotechnology companies hold the largest share in end users segment. Contract research organizations are anticipated to grow at a faster pace during the forecast period. North America is the largest market for mycoplasma testing market due to increasing demand for fast, accurate and affordable diagnosis in healthcare. In addition, spending in R&D activities is expected to enhance developments and rising government funding for pharmaceutical and biotechnology sector in North America is also boosting the growth of mycoplasma testing markets. Asia Pacific is expected to witness fastest growth on account of rapidly increasing demand for advanced healthcare technologies, funding initiatives generated by the Indian government to promote R&D activities in biopharmaceutical industries. Some of the significant players in global mycoplasma testing market are Abbott, American Type Culture Collection, Beckman Coulter/Danaher, Becton Dickinson, Biological Industries, Israel Beit Haemek Ltd., Bionique Testing Laboratories, Inc., Charles River Laboratories International, Inc., InvivoGen, Lonza Group Ltd., Merck KGaA, Promo Cell GmbH, Qiagen, Roche, Sigma-Aldrich and Thermo Fisher Scientific, Inc. Regions Covered: • North America o US o Canada o Mexico • Europe o Germany o France o Italy o UK o Spain o Rest of Europe • Asia Pacific o Japan o China o India o Australia o New Zealand o Rest of Asia Pacific • Rest of the World o Middle East o Brazil o Argentina o South Africa o Egypt What our report offers: - Market share assessments for the regional and country level segments - Market share analysis of the top industry players - Strategic recommendations for the new entrants - Market forecasts for a minimum of 6 years of all the mentioned segments, sub segments and the regional markets - Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations) - Strategic recommendations in key business segments based on the market estimations - Competitive landscaping mapping the key common trends - Company profiling with detailed strategies, financials, and recent developments - Supply chain trends mapping the latest technological advancements About Stratistics MRC We offer wide spectrum of research and consulting services with in-depth knowledge of different industries. We are known for customized research services, consulting services and Full Time Equivalent (FTE) services in the research world. We explore the market trends and draw our insights with valid assessments and analytical views. We use advanced techniques and tools among the quantitative and qualitative methodologies to identify the market trends. Our research reports and publications are routed to help our clients to design their business models and enhance their business growth in the competitive market scenario. We have a strong team with hand-picked consultants including project managers, implementers, industry experts, researchers, research evaluators and analysts with years of experience in delivering the complex projects. For more information, please visit: http://www.strategymrc.com For more information, please visit http://www.strategymrc.com/


PMR's report titled "Global Market Study on Wood Preservative Chemicals and Coatings Active Ingredients: Asia Pacific and Europe Collectively Estimated to Account for About 3/5th of the Global Market Value Share by 2017 End" further reveals that increasing concerns over health risks associated with wood preservatives have been majorly limiting the overall growth of the market. Of late, an alarming rise in incidences of carcinomas, adenomas, malignant phenochromocytomas and hemangiomas has been observed, which is primarily attributed to the increased exposure to pentachlorophenols present in wood preservatives. Many of such preservatives can often be the cause of lethal health hazards. Therefore, manufacturers are shifting towards products which are sustainable and are safer for use in the human vicinity. Development of eco-friendly active ingredients for wood preservative chemicals such as azoles, IPBC, and permethrin is expected to shape the dynamics of the market in the forthcoming years. Janssen Preservation & Material Protection, Lanxess AG, BASF Wolman GmbH, Kurt Obermeier, GmbH & Co. KG, RUTGERS Organics GmbH, Sarpap & Cecil Industries, Koopers Holdings Inc, Lonza Group AG, Troy Corporation, Akzo Nobel N.V. and PPG Industries, Inc. are some of the leading market players profiled in the PMR's report. A sample of this report is available upon request@ http://www.persistencemarketresearch.com/samples/15922 Request to View Report Table of Contents, Figures, and Tables@ Here Amongst regions, the market in Asia-Pacific excluding Japan (APEJ) is expected to remain dominant over 2025. The region is expected to account for approximately 38.7% revenue share of the market by 2017-end. In addition, China is expected to emerge as a key production as well as consumption base for wood preservative chemicals and coatings active ingredient in the near future. Meanwhile, in North America and Europe, countries such as the U.S. and Germany is expected present lucrative business opportunities for manufacturers. Wood Preservative Chemicals and Coatings Active Ingredients Market Report 2017-2025 is available for $4900 (Single User License) @ http://www.persistencemarketresearch.com/checkout/15922 Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance. To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.


PMR's report titled "Global Market Study on Wood Preservative Chemicals and Coatings Active Ingredients: Asia Pacific and Europe Collectively Estimated to Account for About 3/5th of the Global Market Value Share by 2017 End" further reveals that increasing concerns over health risks associated with wood preservatives have been majorly limiting the overall growth of the market. Of late, an alarming rise in incidences of carcinomas, adenomas, malignant phenochromocytomas and hemangiomas has been observed, which is primarily attributed to the increased exposure to pentachlorophenols present in wood preservatives. Many of such preservatives can often be the cause of lethal health hazards. Therefore, manufacturers are shifting towards products which are sustainable and are safer for use in the human vicinity. Development of eco-friendly active ingredients for wood preservative chemicals such as azoles, IPBC, and permethrin is expected to shape the dynamics of the market in the forthcoming years. Janssen Preservation & Material Protection, Lanxess AG, BASF Wolman GmbH, Kurt Obermeier, GmbH & Co. KG, RUTGERS Organics GmbH, Sarpap & Cecil Industries, Koopers Holdings Inc, Lonza Group AG, Troy Corporation, Akzo Nobel N.V. and PPG Industries, Inc. are some of the leading market players profiled in the PMR's report. A sample of this report is available upon request@ http://www.persistencemarketresearch.com/samples/15922 Request to View Report Table of Contents, Figures, and Tables@ Here Amongst regions, the market in Asia-Pacific excluding Japan (APEJ) is expected to remain dominant over 2025. The region is expected to account for approximately 38.7% revenue share of the market by 2017-end. In addition, China is expected to emerge as a key production as well as consumption base for wood preservative chemicals and coatings active ingredient in the near future. Meanwhile, in North America and Europe, countries such as the U.S. and Germany is expected present lucrative business opportunities for manufacturers. Wood Preservative Chemicals and Coatings Active Ingredients Market Report 2017-2025 is available for $4900 (Single User License) @ http://www.persistencemarketresearch.com/checkout/15922 Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance. To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.


— Global Antimicrobial Additives Industry Report offers market overview, segmentation by types, application, countries, key manufactures, cost analysis, industrial chain, sourcing strategy, downstream buyers, marketing strategy analysis, distributors/traders, factors affecting market, forecast and other important information for key insight. Companies profiled in this report are Basf, The Dow Chemical Company, Clariant, A. Schulman, Steritouch, Polyone, Sanitized, Microban International, Biocote, Lonza Group, Biosafe, Milliken Chemical, Nolla Antimicrobial, Rtp Company, Addmaster Limited, Plastics Color Corporation, Nanobiomatters, Agion Technologies, Bayer Materialscience, Ciba Specialty Chemicals Corporation, Teknor Apex, Troy Corporation, Momentive Performance Materials, Arkema Group, Parx Plastic Bv (Netherlands), Porex Corporation, Americhem in terms of Basic Information, Manufacturing Base, Sales Area and Its Competitors, Sales, Revenue, Price and Gross Margin (2012-2017). Split by Product Types, with sales, revenue, price, market share of each type, can be divided into • Silver • Copper • Zinc Split by applications, this report focuses on sales, market share and growth rate of Antimicrobial Additives in each application, can be divided into • Packaging • Food & Beverage • Construction • Automotive Purchase a copy of this report at: https://www.themarketreports.com/report/buy-now/501897 Table of Content: 1 Antimicrobial Additives Market Overview 2 Global Antimicrobial Additives Sales, Revenue (Value) and Market Share by Manufacturers 3 Global Antimicrobial Additives Sales, Revenue (Value) by Countries, Type and Application (2012-2017) 4 Global Antimicrobial Additives Manufacturers Profiles/Analysis 5 North America Antimicrobial Additives Sales, Revenue (Value) by Countries, Type and Application (2012-2017) 6 Latin America Antimicrobial Additives Sales, Revenue (Value) by Countries, Type and Application (2012-2017) 7 Europe Antimicrobial Additives Sales, Revenue (Value) by Countries, Type and Application (2012-2017) 8 Asia-Pacific Antimicrobial Additives Sales, Revenue (Value) by Countries, Type and Application (2012-2017) 9 Middle East and Africa Antimicrobial Additives Sales, Revenue (Value) by Countries, Type and Application (2012-2017) 10 Antimicrobial Additives Manufacturing Cost Analysis 11 Industrial Chain, Sourcing Strategy and Downstream Buyers 12 Marketing Strategy Analysis, Distributors/Traders 13 Market Effect Factors Analysis 14 Global Antimicrobial Additives Market Forecast (2017-2022) 15 Research Findings and Conclusion 16 Appendix Inquire more for more details about this report at: https://www.themarketreports.com/report/ask-your-query/501897 For more information, please visit https://www.themarketreports.com/report/2017-2022-global-top-countries-antimicrobial-additives-market-report


DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Mycoplasma Testing Market Analysis By Product, By Technology (PCR, ELISA, Direct Assay, Microbial Culture Techniques), By Application (Cell Line, Virus, & End of Production Cells Testing), By End-use, And Segment Forecasts, 2014 - 2025" report to their offering. The global mycoplasma testing market is expected to reach a value of USD 1.4 billion by 2025 With growing R&D investments in the field of life sciences, the demand for mycoplasma testing products are anticipated to rise in the near future. Huge opportunities in the life sciences segment are spurring the market growth. Hence, a large amount of investment is being made in the biotechnology and pharmaceutical industries with rising level of healthcare spending across the globe. This is expected to trigger high growth of mycoplasma testing market. Investment in R&D activities by pharmaceutical and biotechnology companies is increasingly being supported by the government. Researches involving drug discovery and development, receive funding from the governmental bodies to a great extent. Moreover, governmental initiatives in the form of awareness campaigns for chronic diseases such as cancer are also encouraging research-based activities. Thus, the aforementioned factors are expected to drive the market growth. Mycoplasma contamination of cell culture is a growing concern for most of the research scientists for decades. Mycoplasma infection arises majorly from laboratory workers as human mycoplasma contamination occurs at a faster rate. In order to combat further contamination, mycoplasma tests are being conducted, which is expected to increase the demand of the related products. Some of the key players are Merck KGaA; Sigma-Aldrich Co.; Thermo Fisher Scientific; Lonza Group Ltd.; Charles River Laboratories International, Inc.; PromoCell GmbH; and Bionique Testing Laboratories, Inc. For more information about this report visit http://www.researchandmarkets.com/research/mfs23g/mycoplasma

Loading Lonza Group collaborators
Loading Lonza Group collaborators